←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Gene Editing, CRISPR Therapy
Luhan Yang
PhD
🏢Qihan Biotech🌐China
Co-founder and CEO, Qihan Biotech
35
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Luhan Yang is a pioneer of multiplex CRISPR editing and co-founded eGenesis and Qihan Biotech to translate CRISPR into transplantation and cancer cell therapies. Her work on PERV inactivation in pigs enabled xenotransplantation research. At Qihan Biotech she is developing allogeneic CRISPR-edited cell therapies for cancer.
Share:
🧪Research Fields 研究领域
CRISPR multiplex editing
xenotransplantation
allogeneic cell therapy
cancer immunotherapy
CAR-T engineering
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Luhan Yang 的研究动态
Follow Luhan Yang's research updates
留下邮箱，当我们发布与 Luhan Yang（Qihan Biotech）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment